Fed Sinks Markets
Health Care: Health Services
Mela Sciences Inc. (MELA: NASDAQ)
$0.80 -0.03 | -3.42%
06/19/13 - 04:00 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
| MELA | Sector Avg. | S&P 500 |
|---|---|---|
| n/a | 0.00 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| -29.20 | -71.43 | -88.54 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 0.00 | 0.00 | |
| Net Income | 0.23 | 0.00 | |
| EPS | -0.23 | 0.00 |
Earnings for MELA:
| EBITDA | -21.00 |
| REVENUE | 278.46K |
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $-0.17 | $-0.18 | $-0.72 | $-0.74 |
| Number of Analysts | 1 | 1 | 1 | 1 |
| High Estimate | $-0.17 | $-0.18 | $-0.72 | $-0.74 |
| Low Estimate | $-0.17 | $-0.18 | $-0.72 | $-0.74 |
| Prior Year | $-0.18 | $-0.17 | $-0.74 | $-0.72 |
| Growth Rate (Year over Year) | 5.56% | -5.88% | 2.70% | -2.78% |
Portfolios with MELA
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- Contributor5 Stocks Under-$10 Setting ...
- ContributorBreakout Stocks Of The Week...
- UserMy Portfolio
- UserThe pick
- Usergrn8nrg Portfolio 1
Latest MELA Headlines from TheStreet
- Joseph V. Gulfo Resigns As CEO Of MELA Sciences; Robert C. Coradini Named Interim CEO; David Stone Elected Chairman Of The Board 06.17.13 | 08:06 am
- MELA Sciences Announces First Quarter 2013 Financial Results 04.30.13 | 04:04 pm
- 5 Stocks Under $10 Set to Soar 04.25.13 | 01:04 pm
- MELA Sciences To Host Investor Meeting In Conjunction With Melanoma Monday On May 6th 2013 In New York 04.18.13 | 04:04 pm
- MELA Sciences To Participate In Upcoming 12th Annual Needham Healthcare Conference 04.15.13 | 04:04 pm
- MELA Sciences To Release First Quarter 2013 Financial Results And Host Conference Call On Tuesday, April 30, 2013 04.10.13 | 04:04 pm
- MELA Sciences Announces Fourth Quarter And Year End 2012 Financial Results 03.05.13 | 04:03 pm
- MELA Sciences Prices Public Offering Of Common Stock; Termination Of At The Market (ATM) Equity Offering Program; And Execution Of Term Sheet For Debt Financing 02.12.13 | 08:02 am
- MELA Sciences To Release Fourth Quarter And Year End 2012 Financial Results And Host Conference Call On Tuesday, March 5, 2013 02.04.13 | 08:02 am
- MELA Sciences To Present At Upcoming Investor Conferences 01.28.13 | 08:01 am
Press Releases for MELA
- MELA Sciences, Inc. Rings NASDAQ Opening Bell With Leading Dermatologists To Raise Awareness For Melanoma Detection And Prevention - PR Newswire 05.06.13 | 09:05 am
- MELA Sciences, Inc. Partners With Dermatologists Nationwide To Promote Skin Cancer Awareness - PR Newswire 04.23.13 | 08:04 am
- MELA Sciences, Inc. Presents New Data That Reinforces The Importance Of MelaFind® As A Diagnostic Tool At AAD Meeting - PR Newswire 03.18.13 | 09:03 am
- Epidemic Increases In Melanoma Rates Three Of Four Americans Surveyed Have Never Had Skin Cancer Examination - PR Newswire 02.21.13 | 07:02 am
- MELA Sciences To Participate In Upcoming 15th Annual Needham Growth Conference - PR Newswire 01.04.13 | 08:01 am
- MELA Sciences Names Rpr Marketing Communications As Its New Agency Of Record - PR Newswire 01.03.13 | 08:01 am
- Potential Shareholder Claims Against Mela Sciences Investigated By Goldfarb Branham Law Firm LLP - Business Wire 12.01.10 | 09:12 am
- The Law Office Of Robbins Umeda LLP Announces An Investigation Of MELA Sciences, Inc. - Business Wire 11.18.10 | 01:11 pm
- Bronstein, Gewirtz & Grossman, LLC Investigating Possible Securities Law Violations At MELA Sciences, Inc. - Business Wire 11.17.10 | 02:11 pm
- Kahn Swick & Foti, LLC And Former Louisiana Attorney General Announce Investigation Into MELA Sciences, Inc. - MELA - Business Wire 11.16.10 | 06:11 pm
Partner Headlines for MELA
- MELA Sciences Pops 10% on Positive Results in German Clinical Study - Benzinga 07.09.12 | 01:07 pm
- MELA Sciences to Sell $20M Shares Through 'at-the-market' Equity Offering Program - Benzinga 06.15.12 | 07:06 pm
- Verisante Technology: The Future Of Cancer Detection - Seeking Alpha 11.21.11 | 08:11 am
- Company News for September 27, 2011 - Corporate Summary - Zacks 09.27.11 | 10:09 am
- Notable Put Options Activity in MELA Sciences - Benzinga 09.27.11 | 09:09 am
- Morning Market Movers - Benzinga 09.26.11 | 09:09 am
- Company News for September 8, 2011 - Corporate Summary - Zacks 09.08.11 | 10:09 am
- Morning Market Movers - Benzinga 09.07.11 | 09:09 am
- 4 Small Caps Likely to Rebound? - Seeking Alpha 12.12.10 | 09:12 am
- Friday Options Recap - Seeking Alpha 11.19.10 | 03:11 pm
